Inventor
MICHAEL LOUIS MILLER
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds22%
C07KPeptides19%
A61KPreparations for medical, dental or toiletry purposes16%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
C07CAcyclic or carbocyclic compounds9%
Y02PClimate change mitigation technologies in the production or processing of goods9%
C07BGeneral methods of organic chemistry6%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
PatentTitleYear
11,981,687Methods of preparing cytotoxic benzodiazepine derivatives2024RE049918Cytotoxic benzodiazepine derivatives202411,793,885Substituted benzo[5,6][1,4]diazepino[1,2-a]indoles for the treatment of proliferative disorders202311,760,759Process for preparing substituted indolines202311,732,038Conjugates comprising cell-binding agents and cytotoxic agents202311,505,617Benzodiazepine derivatives202211,420,982Methods of preparing cytotoxic benzodiazepine derivatives202211,390,633Methods of preparing cytotoxic benzodiazepine derivatives2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to IMMUNOGEN INC (8)· patent assignee history
2022–2024Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IMMUNOGEN INC | 8 | 2022–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2022–2024 |